Cancer Imaging Program (CIP)
The NCI Cancer Imaging Program (CIP) fosters advances in in vivo medical imaging sciences through support of basic and applied research in cancer imaging as well as promotion of imaging in clinical trials in order to gain greater understanding of the pathways of cancer biology for the benefit of cancer patients and people at cancer risk.
CIP Resources
-
NCI Alliance for Nanotechnology in CancerUsing nanotechnology to improve cancer diagnosis, treatment, and prevention
-
Cancer Imaging ArchiveThe Cancer Imaging Archive (TCIA) is a service which de-identifies and hosts a large publicly available archive of medical images of cancer.
-
Quantitative Imaging NetworkPromotes research, development and clinical validation of quantitative imaging tools and methods.
-
Co-Clinical Imaging ResearchFocusing on optimization of quantitative imaging methods for precision medicine in preclinical and clinical settings.
Cancer Imaging Program (CIP) Organization
Funding Opportunities
-
Co-infection and Cancer (R21 Clinical Trial Not Allowed)
Announcement Number: PAR-25-083
-
Imaging, biomarkers and digital pathomics for the early detection of premetastatic cancer
Announcement Number: PAR-22-131
-
Innovative Research in Cancer Nanotechnology (Clinical Trial Not Allowed)
Announcement Number: PAR-25-106